ArticleInternational journal of hematology2016
Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan.
Haruhiko Ninomiya et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled ittrialcites it